London-based RevEng has raised $4.15 million in seed funding, backed by Sands Capital, In-Q-Tel Capital, IQ Capital, and ...

Left unaddressed, prompt injection could become a mainstream evasion tactic used by threat actors, say Check Point ...

In doing so, it has also identified a way to reverse that damage and restore lung function. We already know that exposure to air pollution is bad for us , and it’s particularly damaging for our ...

A drug developed using artificial intelligence showed signs of efficacy in treating an incurable lung disease in what its developer calls a clinical first.

Telomir Pharmaceuticals recently announced preclinical data evaluating its novel oral therapeutic, Telomir-1, for the treatment of age-related macular degeneration (AMD).. The drug demonstrated a ...